nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—duodenum cancer	0.386	0.386	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—GAST—duodenum cancer	0.0302	0.0302	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.027	0.027	CbGpPWpGaD
Scopolamine—SI—Disease—MEN1—duodenum cancer	0.0237	0.0237	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—GAST—duodenum cancer	0.0213	0.0213	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—GAST—duodenum cancer	0.0212	0.0212	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.019	0.019	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.019	0.019	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—SST—duodenum cancer	0.018	0.018	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0167	0.0167	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—SCT—duodenum cancer	0.0151	0.0151	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—SCT—duodenum cancer	0.0145	0.0145	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0143	0.0143	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0137	0.0137	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—SST—duodenum cancer	0.012	0.012	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—SST—duodenum cancer	0.0109	0.0109	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—SST—duodenum cancer	0.0105	0.0105	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—SCT—duodenum cancer	0.0102	0.0102	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—SCT—duodenum cancer	0.0101	0.0101	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—SCT—duodenum cancer	0.01	0.01	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00966	0.00966	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00963	0.00963	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.00954	0.00954	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—GAST—duodenum cancer	0.009	0.009	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—GAST—duodenum cancer	0.00862	0.00862	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—SCT—duodenum cancer	0.00853	0.00853	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GAST—duodenum cancer	0.00817	0.00817	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—SCT—duodenum cancer	0.00817	0.00817	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GAST—duodenum cancer	0.00783	0.00783	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SCT—duodenum cancer	0.00775	0.00775	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SCT—duodenum cancer	0.00742	0.00742	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—SST—duodenum cancer	0.00736	0.00736	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—SST—duodenum cancer	0.00733	0.00733	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—SST—duodenum cancer	0.00726	0.00726	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—SST—duodenum cancer	0.00617	0.00617	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GAST—duodenum cancer	0.00607	0.00607	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GAST—duodenum cancer	0.00605	0.00605	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GAST—duodenum cancer	0.00599	0.00599	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—SST—duodenum cancer	0.00591	0.00591	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—SCT—duodenum cancer	0.00575	0.00575	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—SCT—duodenum cancer	0.00573	0.00573	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—SCT—duodenum cancer	0.00568	0.00568	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SST—duodenum cancer	0.0056	0.0056	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GAST—duodenum cancer	0.00551	0.00551	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GAST—duodenum cancer	0.00549	0.00549	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GAST—duodenum cancer	0.00544	0.00544	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SST—duodenum cancer	0.00536	0.00536	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SCT—duodenum cancer	0.00522	0.00522	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SCT—duodenum cancer	0.00521	0.00521	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SCT—duodenum cancer	0.00516	0.00516	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GAST—duodenum cancer	0.00483	0.00483	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GAST—duodenum cancer	0.00462	0.00462	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SCT—duodenum cancer	0.00458	0.00458	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SCT—duodenum cancer	0.00438	0.00438	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—SST—duodenum cancer	0.00416	0.00416	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—SST—duodenum cancer	0.00415	0.00415	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—SST—duodenum cancer	0.0041	0.0041	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MEN1—duodenum cancer	0.004	0.004	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MEN1—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SST—duodenum cancer	0.00378	0.00378	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SST—duodenum cancer	0.00376	0.00376	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SST—duodenum cancer	0.00373	0.00373	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SST—duodenum cancer	0.00331	0.00331	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GAST—duodenum cancer	0.00325	0.00325	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GAST—duodenum cancer	0.00324	0.00324	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GAST—duodenum cancer	0.00321	0.00321	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SST—duodenum cancer	0.00317	0.00317	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SCT—duodenum cancer	0.00309	0.00309	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SCT—duodenum cancer	0.00308	0.00308	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SCT—duodenum cancer	0.00305	0.00305	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEN1—duodenum cancer	0.0027	0.0027	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEN1—duodenum cancer	0.00269	0.00269	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEN1—duodenum cancer	0.00266	0.00266	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SST—duodenum cancer	0.00223	0.00223	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SST—duodenum cancer	0.00222	0.00222	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SST—duodenum cancer	0.0022	0.0022	CbGpPWpGaD
